Experimental cancer drug trial halted early
NCT ID NCT06188208
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 36 times
Summary
This early-stage study tested a new drug called VVD-130850, which blocks a protein (STAT3) that helps cancers grow. The trial aimed to find a safe dose and see if the drug works, both alone and with another immunotherapy, in people with advanced solid tumors or blood cancers. The study was terminated before completion, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Blacktown Hospital
Blacktown, New South Wales, Australia
-
California Research Institute
Los Angeles, California, 90027, United States
-
Cancer Research South Australia
Adelaide, Australia
-
Florida Cancer Specialists
Sarasota, Florida, 34232, United States
-
Gold Coast University Hospital
Southport, Queensland, Australia
-
Hospital Universitario 12 de Octubre
Madrid, Spain
-
ICON Cancer Research
South Brisbane, Australia
-
MDACC
Houston, Texas, 77030, United States
-
NEXT Austin
Austin, Texas, 78758, United States
-
NEXT Dallas
Irving, Texas, 75039, United States
-
NEXT Madrid
Madrid, Spain
-
NEXT San Antonio
San Antonio, Texas, 78299, United States
-
NEXT Virginia
Fairfax, Virginia, 22031, United States
-
Orange Health Service
Orange, New South Wales, Australia
-
START Barcelona Hospital HM Nou Delfos
Barcelona, Spain
-
START Madrid CIOCC
Madrid, Spain
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
Start Madrid-FJD, Hospital Fundacion Jimenez Diaz
Madrid, Spain
-
University of Utah Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
-
Vall d'Hebron
Barcelona, Spain
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.